Drop is a product system, designed to empower glaucoma patients to self-administer preservative-free medication.
Harry MoormanActuated & Rest StateThe image shows the device in its actuated and rest states, indicating how users interact with the product.
Harry MoormanDesign for ManufactureExploded view of the device, detailing the internal components and DFM features.
Harry MoormanCap removalThe cap can be removed to allow access to the medication nozzle and forehead grip.
Harry MoormanDevice in hand
Harry MoormanDevelopment (1)A multitude of development techniques were utilised during the project process, from digital and hand sketching, to 2D illustrator renderings and CAD.
Harry MoormanDevelopment (2)A multitude of development techniques were utilised during the project process, from digital and hand sketching, to 2D illustrator renderings and CAD.
Harry MoormanDevice in useThe device can be rested on the forehead to increase stability. Users use the blue grip to align the nozzle above their eye, and squeeze the two buttons together to administer a dose.
Harry MoormanDevice in dockThe dock stores the device, completing the system and keeping all product components in a single location.
Harry MoormanMedication removalSpare medication bottles can be stored in the dock.
Harry MoormanProduct system
Harry MoormanMedication replacement
Harry MoormanDevice undersideUnderside detailing on the device allows users to easily position the device over their eye.
Open-angle glaucoma is a chronic condition affecting over 60million people worldwide. An increase of intraocular pressure causes damage to the optic nerve, resulting in irreversible vision loss. Topical eyedrops are commonly prescribed to manage the condition and prevent further vision loss, but numerous usability issues result in poor patient-drug relationships, affecting medication adherence.
Prescribed medication often contains preservatives to maintain medication sterility, but continued exposure to this preservative can cause Ocular Surface Disease over time. Preservative-free medications are available, but only in single-dose ampoules, which have a huge environmental impact. In addition, patients struggle to administer their eyedrops correctly; dexterity issues can result in difficulty aligning the nozzle above the eye, whilst varying dose sizes can lead to discrepancies regarding medication efficacy. Finally, healthcare-providers desire a way to track patient-specific medication adherence but are currently unable to do so.
Drop empowers glaucoma patients to self-administer preservative-free medication, whilst tracking device use and medication adherence.
The product streamlines the administration of ophthalmic medication, utilising the forehead as a rest increases stability and assists users to correctly align the nozzle above their eye. A simple squeeze actuation pumps a consistently sized dose of medication into the users eye, whilst smart technology tracks adherence and populates patient-specific healthcare records - supplying the healthcare-provider with important data. It capitalises on an untapped, growing market and brings real value to an infirm and in need user group.